Prescribing Tessalon (Benzonatate) for a 65-Year-Old Female with Cough
For a 65-year-old female with cough, prescribe Tessalon (benzonatate) 100-200 mg three times daily as needed, with a maximum of 600 mg daily in three divided doses, but only if the cough is due to chronic bronchitis—not if it's from an upper respiratory infection (URI) or common cold, where benzonatate has limited efficacy. 1
Critical First Step: Determine the Cause of Cough
Before prescribing any cough suppressant, you must identify whether this is:
- Chronic bronchitis: Peripheral cough suppressants like benzonatate are recommended (Grade A) 2
- Acute URI/common cold: Peripheral cough suppressants have limited efficacy and are NOT recommended (Grade D) 2
- Postinfectious cough (3-8 weeks post-URI): Consider ipratropium bromide first, then inhaled corticosteroids 2
Dosing Instructions (FDA-Approved)
Standard dosing 1:
- Start with 100 mg or 200 mg capsules three times daily as needed
- Maximum: 600 mg daily in three divided doses
- Duration of action: 3-8 hours
- Onset: 15-20 minutes
Critical Safety Warning
The capsules MUST be swallowed whole—never broken, chewed, dissolved, cut, or crushed 1. This is essential because benzonatate acts as a local anesthetic; if released in the mouth, it can cause severe oropharyngeal anesthesia, choking risk, and potentially fatal complications.
When Benzonatate Is Appropriate
Use benzonatate for 2:
- Chronic bronchitis (short-term symptomatic relief)
- Acute bronchitis (short-term symptomatic relief)
Do NOT use benzonatate for 2:
- Acute cough from URI/common cold (Grade D—limited efficacy)
- Asthma-related cough (use asthma-directed therapy instead)
- Neuromuscular impairment (ineffective, Grade D)
Alternative Considerations Based on Cough Etiology
If the cough is from URI/common cold 2:
- Central cough suppressants (codeine, dextromethorphan) also have limited efficacy (Grade D)
- Consider older antihistamine-decongestant combinations instead
- Zinc preparations are NOT recommended (Grade D)
If the cough is from chronic bronchitis 2:
- Benzonatate is appropriate (Grade A)
- Alternative: Central suppressants like codeine or dextromethorphan (Grade B)
- Ipratropium bromide inhaled is also effective (Grade A)
Mechanism and Expectations
Benzonatate works peripherally by anesthetizing stretch receptors in the respiratory passages, lungs, and pleura, thereby dampening the cough reflex at its source 1. It does not suppress the respiratory center at recommended doses, making it safer than central-acting agents in this regard.
Common Pitfalls to Avoid
- Don't prescribe for viral URI cough: The evidence shows peripheral suppressants like benzonatate have limited efficacy in acute viral coughs 2
- Don't assume all coughs respond equally: Chronic bronchitis responds; acute URI does not
- Emphasize swallowing whole: Patient education is critical to prevent local anesthetic complications
- Don't use long-term: These are for short-term symptomatic relief only
Clinical Context
The ACCP guidelines are clear that the efficacy of peripheral cough suppressants is context-dependent 3, 2. While benzonatate has substantial benefit in chronic/acute bronchitis (Grade A), it has essentially no benefit in URI-related cough (Grade D). This distinction is crucial for appropriate prescribing in your 65-year-old patient.